Alcohol-related intoxications associated with adulterated distilled beverages represent a persistent and preventable public health challenge, particularly in settings characterized by informal alcohol markets, weak regulatory oversight, and limited product traceability. In recent years, an increasing number of poisoning episodes worldwide have been linked to methanol, a highly toxic alcohol not intended for human consumption and frequently detected in falsified or illicitly produced distilled beverages (Hay, 2017; Alrashed et al., 2024). Methanol contamination commonly arises from illicit production practices, substitution with industrial alcohols, or inadequate quality control within informal supply chains, substantially increasing the risk of mass exposure.
In contrast to ethanol intoxication, which is typically dose-dependent and often reversible, methanol poisoning is characterized by delayed symptom onset and rapid metabolic deterioration due to the accumulation of toxic metabolites, particularly formic acid (Barceloux et al., 2000; Kraut and Mullins, 2018). The clinical evolution frequently includes severe metabolic acidosis, visual impairment resulting from optic nerve toxicity, and neurological damage involving the central nervous system. Once symptoms become clinically apparent, disease progression may be rapid, often leading to irreversible sequelae or death if timely treatment is not initiated. The nonspecific nature of early manifestations—commonly resembling uncomplicated ethanol intoxication or alcohol hangover contributes to diagnostic delays and worsens clinical outcomes (Anvisa, 2025; Brazil Agency, 2025a; CNN Brazil, 2025b).
Methanol-related outbreaks reported in Brazil during 2025 raised significant concern among health authorities due to the number of fatalities and cases of permanent disability documented. These events exposed persistent vulnerabilities in surveillance systems, regulatory enforcement, and risk communication, particularly in contexts dominated by informal alcohol markets and limited traceability. Collectively, this scenario reinforced the classification of these episodes as public health emergencies and underscored the urgent need for integrated strategies aimed at early detection, prevention, and coordinated outbreak response (Figure 1) (Anvisa, 2025; Brazil Agency, 2025a; CNN Brazil, 2025b).
Figure 1: Hepatic metabolism of ethanol. Ethanol is oxidized to acetaldehyde by alcohol dehydrogenase (ADH) in the cytosol, and acetaldehyde is subsequently converted to acetate by Aldehyde Dehydrogenase (ALDH) in the mitochondria
Brazil has reported multiple episodes of alcohol-related intoxication over recent decades, with outbreaks frequently associated with the illicit production and distribution of distilled beverages (Hay, 2017; Manning and Kowalska, 2021; Bryan et al., 2024). These events have been documented across different regions of the country and have disproportionately affected socially vulnerable populations, often occurring outside regulated commercial channels where product quality control, consumer protection, and effective traceability mechanisms are limited (OECD, 2022; Movendi International, 2025). Such conditions facilitate the circulation of adulterated beverages and hinder timely detection by regulatory and health surveillance systems.
Surveillance data and clinical reports consistently indicate that methanol-related poisonings, although less frequent than ethanol intoxication, are associated with substantially higher lethality and more severe clinical outcomes (Zakharov et al., 2014; Gulen et al., 2020; Alhusain et al., 2024). Periodic surges in reported cases suggest persistent failures in enforcement, product traceability, and early identification of contaminated beverages within informal markets. These gaps have been highlighted by national and international public health agencies and media reports documenting recurrent episodes of blindness, neurological damage, and death associated with methanol-laced alcohol (Anvisa, 2025; Food Safety News, 2025; The Guardian, 2025).
Epidemiological estimates further indicate that approximately 13.8% of all alcohol consumed in the Americas is unrecorded, encompassing informal, illicit, and surrogate products. This substantial proportion of unregulated consumption markedly increases the risk of exposure to toxic contaminants such as methanol, particularly in settings characterized by weak regulatory oversight and limited surveillance capacity (PAHO/WHO, 2025). Comparative analyses consistently demonstrate that case fatality rates associated with methanol intoxication are significantly higher than those observed for ethanol-related poisoning, reflecting both fundamental toxicological differences and frequent delays in diagnosis and treatment (Kraut and Mullins, 2018; Salehtabari et al., 2025).
Beyond national contexts, methanol poisoning constitutes a significant global public health problem. Estimates from Médecins Sans Frontières suggest that approximately 40,000 individuals worldwide have been affected by methanol intoxication since 1998, resulting in an estimated 14,400 deaths, although these figures likely underestimate the true burden due to underdiagnosis and incomplete surveillance (MSF Norway et al., 2019). International public health alerts emphasize that recurrent methanol outbreaks represent a largely preventable cause of mortality and long-term disability, underscoring the need for coordinated surveillance systems, regulatory action, and public awareness strategies at both national and international levels (Hay, 2017; Nekoukar et al., 2021; Movendi International, 2025).
Figure 2: Hepatic metabolism of methanol. Methanol is oxidized to formaldehyde by Alcohol Dehydrogenase (ADH) in the cytosol, and formaldehyde is subsequently converted to formic acid by Aldehyde Dehydrogenase (ALDH), leading to the accumulation of the toxic metabolite
Within this context, the present study aims to analyze methanol-related intoxications associated with adulterated distilled beverages in Brazil between 2017 and 2025, with particular emphasis on the outbreak configuration observed in 2025. The study seeks to characterize clinical severity through qualitative outcomes, including deaths and permanent sequelae such as visual and neurological impairment. Additionally, it aims to differentiate methanol intoxication from ethanol-related events, including exposures involving fuel or industrial ethanol and alcohol-based disinfectants. Finally, a structured review of the scientific literature by thematic area is conducted to support prevention strategies, regulatory actions, and risk communication in vulnerable contexts
2.0. METHODS
This study employed a descriptive and analytical design to investigate alcohol-related intoxications associated with methanol-contaminated distilled beverages in Brazil from 2017 to 2025. Data were obtained from official health surveillance systems, epidemiological bulletins, and publicly available clinical reports issued by national and state health authorities. Confirmed and probable cases were included, and outcomes were classified according to mortality and the presence of permanent sequelae, such as visual or neurological impairment. Ethanol-related intoxications were considered solely for contextual comparison and were not included in outcome calculations.
Data extraction followed a standardized protocol to ensure consistency across sources, including verification of duplicated notifications and exclusion of records with incomplete outcome information. Cases were stratified by year, geographic region, and clinical outcome to allow temporal and regional comparisons. The literature review component involved the systematic identification of scientific articles relevant to methanol intoxication, which were subsequently categorized by disciplinary area. This approach enabled an integrated analysis combining epidemiological surveillance data with scientific evidence. All analyses were conducted using descriptive statistical techniques appropriate for observational public health data.
3.0. RESULTS
Between 2017 and 2025, alcohol adulteration events in Brazil were consistently associated with severe clinical outcomes and a substantial burden of long-term morbidity. During the major methanol outbreak reported in 2025, the Brazilian Ministry of Health officially confirmed 47 cases of methanol intoxication, with an additional 57 suspected cases remaining under epidemiological investigation. As of October 20, 2025, nine deaths had been confirmed, while seven further deaths were still under investigation, indicating a lethality profile markedly higher than that observed in typical ethanol-related intoxications. Among individuals who survived acute methanol poisoning, permanent sequelae were frequently documented, most notably visual impairment and neurological dysfunction. Importantly, official surveillance systems did not provide consolidated quantitative estimates of long-term outcomes, reflecting structural limitations in post-acute follow-up and outcome reporting.
A comparable toxic alcohol event not involving methanol further illustrates the persistent and multifaceted burden associated with alcohol adulteration. In the Backer brewery case in Minas Gerais, contamination of beer with monoethylene glycol and diethylene glycol resulted in ten confirmed deaths. Five years after the exposure, multiple survivors continue to experience permanent sequelae, including chronic kidney disease, visual and auditory deficits, facial paralysis, and neurological impairment. In several instances, these long-term effects prevented affected individuals from returning to their previous occupational activities. Together, these observations demonstrate that the health impact of alcohol adulteration extends well beyond acute mortality, generating sustained disability and long-lasting social and economic consequences (Table 1).
Table 1: Comparative summary of major alcohol adulteration events in Brazil, indicating the main adulterants, affected regions, and associated health impacts. The table highlights recurring patterns and public health implications related to alcohol contamination
|
Event |
Year(s) |
Toxic agent |
Cases/deaths |
Key health impacts |
|
Methanol outbreak (Brazil) |
2025 |
Methanol |
47 cases; 9 deaths |
Metabolic acidosis, blindness, and neurological impairment |
|
Methanol outbreak (Brazil) |
2025 |
Methanol |
57 cases under investigation |
Visual toxicity and CNS involvement |
|
Backer Brewery case (Minas Gerais) |
2020–2025 |
Monoethylene glycol |
Multiple cases |
Acute kidney injury |
|
Backer Brewery case (Minas Gerais) |
2020–2025 |
Diethylene glycol |
10 deaths |
High lethality and neurological damage |
|
Backer Brewery case (Minas Gerais) |
2020–2025 |
Glycol compounds |
Included above |
Chronic kidney disease and sensory deficits |
The temporal analysis of alcohol-related intoxications associated with methanol-contaminated distilled beverages between 2017 and 2025 revealed a heterogeneous distribution pattern. Earlier years were characterized predominantly by sporadic or isolated notifications, whereas a pronounced escalation in reported cases occurred in 2025. This latter period exhibited features consistent with a clear outbreak configuration rather than a continuation of isolated or endemic events, suggesting a concentrated point-source exposure. Compared with preceding years, the intensity of reported cases in 2025 substantially exceeded baseline levels described by health authorities. This temporal pattern supports the epidemiological classification of the 2025 episode as an acute public health emergency rather than a persistence of low-level endemic occurrence (Table 2).
Table 2: Temporal pattern of methanol-related intoxication events in Brazil (2017–2025). This table summarizes the qualitative temporal distribution of reported methanol intoxication events, highlighting shifts in occurrence intensity, regulatory context, and epidemiological interpretation
|
Period |
Occurrence pattern |
Regulatory and market context |
Epidemiological interpretation |
Public health implications |
|
2017–2018 |
Isolated notifications |
Routine surveillance; limited visibility of illicit chains |
No outbreak configuration; case-based detection |
Low signal-to-noise; high risk of under-detection |
|
2019 |
Sporadic reports |
Informal market persistence ; inconsistent enforcement |
Early warning signals for adulteration |
Need for targeted vigilance and lab readiness |
|
2020 |
Low but persistent |
Pandemic-era constraints; reduced inspections and shifts to informal sales |
Sustained low-level exposure potential |
Higher likelihood of delayed care and late diagnosis |
|
2021 |
Low but persistent |
Variable municipal capacity; continued circulation of falsified products |
Continued risk without clear clustering |
Opportunities for strengthening toxico-surveillance |
|
2022 |
Moderate increase |
Fragmented responses; ongoing counterfeit distribution |
Emerging cluster-compatible pattern |
Need for rapid differentiation from ethanol intoxication |
|
2023 |
Moderate increase |
Intermittent enforcement ; persistent informal availability |
Expansion of exposure networks |
Cross-sector coordination becomes critical |
|
2024 |
Pre-outbreak escalation |
Delayed corrective actions; limited traceability of products |
High outbreak potential; sentinel events |
Proactive alerts and intensified inspections are recommended |
|
2025 |
Outbreak peak |
Emergency interventions; intensified seizures and public alerts |
Point-source exposure; public health emergency |
High lethality and sequelae burden; urgent risk communication |
Regarding clinical outcomes, fatal cases were frequently reported during the 2025 outbreak, demonstrating a lethality profile substantially more severe than that typically associated with ethanol-related intoxications. Mortality was consistently described as elevated in official communications and clinical summaries, reinforcing the extreme toxicity of methanol when ingested. Deaths commonly followed rapid clinical deterioration after a delayed onset of symptoms, a hallmark of methanol poisoning related to the accumulation of toxic metabolites. These findings highlight the disproportionate contribution of methanol exposure to fatal alcohol-related outcomes despite its comparatively lower prevalence relative to ethanol consumption (Table 3).
Table 3: Clinical outcomes and severity markers associated with methanol intoxication. The table synthesizes outcome categories, typical severity indicators, and clinical relevance, supporting differentiation from ethanol intoxication in emergency settings
|
Outcome/marker |
Relative frequency (qualitative) |
Severity level |
Clinical relevance |
Typical care needs |
|
Fatal outcome |
High in outbreak settings |
Extreme |
Key driver of outbreak burden |
Critical care; advanced support |
|
Severe metabolic acidosis |
High |
Critical |
Proxy for advanced poisoning and poor prognosis |
ICU monitoring; dialysis consideration |
|
Visual impairment (blurred vision/scotomas) |
High |
Severe |
Hallmark of methanol metabolism |
Ophthalmology; antidote; monitoring |
|
Complete blindness |
Moderate |
Severe |
Irreversible disability in many cases |
Rehabilitation; long-term support |
|
Neurological deficits |
Moderate |
Moderate–severe |
Cognitive/motor impairment; functional loss |
Neuro rehab; multidisciplinary care |
|
Respiratory compromise |
Low–moderate |
Severe |
Often secondary to critical illness |
Ventilatory support when needed |
|
Renal complications (secondary) |
Low–moderate |
Moderate |
May reflect multi-organ dysfunction |
Nephrology follow-up |
|
Survival without sequelae |
Low |
Mild |
Uncommon full recovery in severe outbreaks |
Observation; follow-up |
Among individuals who survived the acute intoxication phase, permanent sequelae were commonly reported. Visual impairment emerged as the most frequently documented long-term consequence, ranging from partial visual loss to irreversible blindness. Neurological sequelae, including cognitive deficits and motor dysfunction, were also observed, although less frequently than ophthalmologic damage. Several reports described the coexistence of multiple sequelae within the same individual, indicating multisystem injury. The high prevalence of long-term disability among survivors underscores that the burden of methanol intoxication extends far beyond immediate mortality and persists as a chronic health and social challenge (Table 4).
Table 4: Permanent sequelae reported among survivors of methanol intoxication. This table highlights multisystem long-term complications and their functional consequences, emphasizing the disability burden beyond mortality
|
Sequela type |
Affected system |
Functional impact |
Clinical significance |
|
Partial visual loss |
Ophthalmologic |
Reduced acuity; impaired reading/driving |
Common disabling outcome |
|
Complete blindness |
Ophthalmologic |
Total vision loss; dependence risk |
Permanent disability; major social impact |
|
Optic neuropathy |
Ophthalmologic/neurologic |
Persistent visual-field defects |
Typical methanol signature |
|
Cognitive impairment |
Central nervous system |
Memory/attention deficits; reduced autonomy |
Long-term rehabilitation needs |
|
Motor dysfunction |
Neuromuscular |
Gait disturbance, weakness, and coordination loss |
Chronic mobility limitations |
|
Speech/language difficulties |
Neurologic |
Communication impairment |
Impacts employability and social functioning |
|
Psychiatric symptoms |
Neuropsychiatric |
Anxiety/depression; adjustment disorders |
Often under-recognized; needs follow-up |
|
Functional dependence |
Multisystem |
Reduced ability for daily living activities |
Drives long-term care demand |
Sociodemographic and geographic characterization of reported cases suggested a non-random distribution of exposures. A higher concentration of cases was observed in specific regions and states, consistent with the localized circulation of contaminated beverage batches. Reports frequently involved socially vulnerable populations, particularly individuals with limited access to regulated commercial products and delayed healthcare-seeking behavior. These patterns indicate that structural, economic, and social determinants played a central role in shaping both exposure risk and clinical outcomes during the outbreak period (Table 5).
Table 5: Geographic and sociodemographic vulnerability patterns associated with methanol intoxication. The table summarizes clustering, vulnerable settings, and contextual determinants relevant to prevention strategies
|
Distribution aspect |
Observed pattern |
Likely determinant |
Prevention implication |
|
Geographic clustering |
Concentration in specific states/municipalities |
Localized distribution of contaminated batches |
Target inspections and traceability actions |
|
Informal purchase settings |
Non-licensed points of sale |
Price sensitivity and access barriers to regulated products |
Improve consumer guidance and enforcement |
|
Social vulnerability |
Higher occurrence in low-income contexts |
Economic constraints; limited information access |
Risk communication tailored to vulnerable groups |
|
Delayed care seeking |
Late presentation to services |
Low risk perception; access barriers |
Early warning messages and triage protocols |
|
Mass social events |
Clusters tied to gatherings |
Shared consumption of contaminated beverages |
Rapid cluster detection and alerts |
|
Occupational vulnerability |
Occasional links to informal work contexts |
Exposure in social/occupational gatherings |
Workplace/community outreach |
|
Urban peripheries |
Higher reported risk |
Informal market penetration |
Community-level engagement |
|
Rural/remote areas |
Under-detection risk |
Limited diagnostic capacity and transport barriers |
Strengthen referral and laboratory networks |
Analysis of exposure circumstances indicated that the majority of intoxications were associated with suspected illicit or falsified distilled beverages. In many cases, the precise origin of the consumed products could not be confirmed due to a lack of traceability, reuse of containers, or absence of appropriate labeling. Consumption often occurred in informal social settings rather than licensed establishments, complicating early detection and timely intervention. These exposure characteristics are consistent with point-source outbreaks linked to contaminated batches distributed through informal markets (Table 6).
Table 6: Exposure characteristics, product origin, and regulatory infractions related to methanol-contaminated beverages. This table describes common exposure pathways, product features, and infringementention
|
Exposure component |
Typical description |
Common infractions/irregularities |
Risk implication |
|
Product type |
Distilled spirits (varied categories) |
Mislabeling of content and origin |
Higher methanol concentration risk |
|
Origin |
Illicit or falsified products |
Lack of producer identification; counterfeit branding |
No traceability; delayed recalls |
|
Packaging |
Reused bottles/irregular seals |
Absence of tax seal; tampered caps |
Consumer unable to verify authenticity |
|
Distribution channel |
Informal markets; peer-to-peer sales |
Sales without licensing; no invoices |
Rapid spread before detection |
|
Price signals |
Below-market pricing |
Predatory pricing in illicit trade |
Attracts vulnerable consumers |
|
Label information |
Incomplete or inconsistent |
Missing batch numbers; falsified addresses |
Blocks source tracking |
|
Adulteration motive |
Increase perceived alcohol strength |
Use of industrial alcohols |
Severe toxicity and mass casualties |
|
Traceability failure |
Unknown batch and supply chain |
Non-compliance with recordkeeping |
Limits outbreak containment |
Indicators related to health system response reflected the severity of the outbreak. A substantial proportion of affected individuals required hospital admission, and intensive care was frequently necessary in severe cases. Official responses included product seizures, interdictions, and public risk alerts; however, these measures were often implemented only after multiple severe cases had already occurred. The interval between initial case notifications and large-scale public warnings varied, highlighting operational challenges in outbreak recognition, surveillance sensitivity, and intersectoral response coordination (Table 7).
Table 7: Health system response and regulatory actions during methanol intoxication outbreaks. The table summarizes clinical management components, surveillance actions, and enforcement measures, highlighting operational challenges and opportunities for improvement
|
Response domain |
Observed actions |
Operational challenges |
Improvement opportunity |
|
Emergency triage |
Recognition of toxic alcohol patterns |
Misclassification as ethanol intoxication |
Standardized triage prompts and checklists |
|
Laboratory capacity |
Assessment of acidosis and supportive labs |
Limited access to confirmatory testing |
Expand regional toxicology lab networks |
|
Antidotal therapy |
Use of alcohol dehydrogenase inhibitors/support |
Availability and timing variability |
Protocols and stock management |
|
Extracorporeal treatment |
Dialysis in severe cases |
Resource constraints and referral delays |
Regional referral pathways and criteria |
|
Hospitalization/ICU |
High demand in outbreak peaks |
Bed and staff saturation |
Surge capacity planning |
|
Risk communication |
Public alerts and guidance |
Delayed dissemination to high-risk groups |
Faster multi-channel alert systems |
|
Regulatory enforcement |
Seizures/interdictions and inspections |
Fragmented inter-agency coordination |
Joint operations and traceability enforcement |
|
Case reporting |
Notification to surveillance systems |
Incomplete follow-up outcomes |
Improve follow-up documentation routines |
The literature review component identified a heterogeneous body of scientific publications addressing methanol intoxication. Most studies were concentrated in toxicology and clinical medicine, focusing primarily on pathophysiology, diagnosis, and acute management. In contrast, public health and epidemiological analyses were less frequent, and studies addressing regulation, prevention strategies, and risk communication were comparatively scarce. This distribution reflects a predominance of biomedical perspectives in the literature and a relative underrepresentation of systemic, preventive, and policy-oriented approaches (Table 8).
Table 8: Scientific literature analyzed by thematic area and research gaps. This table synthesizes the dominant disciplinary focus in the reviewed literature and highlights areas requiring strengthened evidence
|
Thematic area |
Typical study focus |
Common study designs |
Key gap/research need |
|
Toxicology |
Mechanisms; metabolism; prognostic markers |
Reviews: experimental/clinical series |
Limited translation into prevention frameworks |
|
Clinical medicine |
Diagnosis; treatment; acute outcomes |
Retrospective cohorts; case series |
Scarce long-term sequelae follow-up |
|
Ophthalmology |
Visual outcomes: optic neuropathy |
Case series; clinical reviews |
Need standardized outcome measurement |
|
Neurology |
Neuroimaging and cognitive outcomes |
Observational studies |
Underrepresentation of rehabilitation pathways |
|
Public health |
Outbreak characterization: determinants |
Descriptive reports; surveillance analyses |
Few evaluations of interventions |
|
Regulation and policy |
Control measures; illicit trade |
Policy analyses |
Limited empirical impact assessments |
|
Risk communication |
Messaging strategies and behaviors |
Qualitative studies |
Low volume of context-specific research |
|
Forensic/analytics |
Detection of adulteration and counterfeits |
Method development |
Need scalable field deployment studies |
Differentiation between beverage-grade ethanol intoxication and exposures involving fuel or industrial ethanol revealed distinct exposure pathways and public health implications. Non-beverage ethanol exposures were predominantly associated with unsafe storage practices, container reuse, and deliberate substitution in informal contexts. These events differ from conventional ethanol intoxication by presenting additional risks related to impurities, denaturants, and the absence of traceability, complicating surveillance and outbreak investigation (Table 9).
Table 9: Differentiation between beverage-grade ethanol and fuel/industrial ethanol exposures in alcohol-related intoxication events. This table summarizes key distinctions between ethanol intended for human consumption and ethanol intended for industrial or fuel purposes, emphasizing exposure pathways and implications for surveillance and prevention
|
Substance/source |
Intended use |
Key characteristics |
Typical misuse/exposure scenario |
Public health implication |
|
Beverage-grade ethanol |
Human consumption |
Food-grade production; quality control |
Excessive drinking; binge episodes |
High population burden; outcomes often dose-dependent |
|
Fuel ethanol (ethanol fuel) |
Automotive fuel |
Not food-grade; potential impurities/adulteration |
Accidental ingestion from fuel containers; repurposed storage |
Severe poisoning risk; requires rapid differentiation from beverage ethanol |
|
Industrial/denatured ethanol |
Solvent/disinfection/industrial processes |
May contain denaturants/impurities; not for ingestion |
Intentional ingestion as a substitute for alcohol; accidental ingestion |
Unpredictable toxicity; surveillance should capture non-beverage alcohol exposure |
|
Alcohol-based products (unknown grade) |
Variable |
Traceability is absent in informal settings |
Use in falsified drinks or unregulated handling |
Complicates outbreak investigation and traceability |
During the COVID-19 period, alcohol-based products widely used for disinfection emerged as an additional source of intoxication risk. Accidental ingestion, particularly among children, and unsafe decanting practices were repeatedly identified as exposure routes. Although distinct from illicit beverage outbreaks, these events contributed to severe intoxications and increased demand for emergency medical care (Table 10).
Table 10: Alcohol-based products widely used for disinfection during COVID-19 and associated intoxication risks. This table synthesizes common alcohol-based disinfection products, intended uses, exposure routes, and prevention messages relevant to poisoning risk during periods of high household and occupational use
|
Product type |
Typical use |
Common exposure routes |
Main poisoning concern |
Prevention message |
|
Alcohol gel hand sanitizer |
Hand hygiene |
Accidental ingestion (children); intentional ingestion |
Ethanol/isopropanol intoxication; contamination risk in poor-quality products |
Store safely; do not ingest; prefer regulated products |
|
Liquid hand sanitizer / rubbing alcohol |
Hand hygiene: quick cleaning |
Ingestion; inhalation in poorly ventilated spaces |
High-dose intoxication; irritant effects |
Use with ventilation; keep away from food containers |
|
Alcohol-based surface disinfectants |
Cleaning tools/surfaces |
Dermal contact; inhalation; accidental ingestion |
Irritation; misuse as an average substitute |
Clear labeling; never ingest; avoid decanting to drink bottles |
|
Alcohol is used to disinfect tools/materials |
Household/occupational cleaning |
Accidental ingestion due to unsafe storage practices |
Confusion with potable liquids; high-dose exposure |
Never store in beverage containers; keep original packaging |
|
Refill/decanted alcohol products |
Convenience storage |
Ingestion from unlabeled containers |
Unknown concentration; mixed products |
Maintain labels; child-proof storage; discard unknown products |
Finally, analysis of exposure characteristics combined with international evidence indicated that distilled beverages are disproportionately represented in methanol adulteration events. Products such as vodka, gin, cachaça, whisky, rum, tequila, and cognac were consistently implicated in outbreak investigations due to high market demand, ease of falsification, and the ability of strong flavors to mask adulteration. In contrast, fermented beverages such as beer, draft beer, and wine typically generate minimal methanol during production, although adulteration remains possible in informal markets. Selected international outbreaks further illustrate the global recurrence of methanol-related intoxication and its severe clinical consequences (Table 11).
Table 11: Alcoholic beverages most susceptible to methanol adulteration and selected international outbreaks. This table summarizes the alcoholic beverage categories most frequently associated with methanol adulteration, with an emphasis on distilled spirits commonly implicated in large-scale poisoning events
|
Category |
Description |
Public health relevance |
|
Distilled beverages at the highest risk |
Vodka, gin, cachaça, whisky, rum, tequila, and cognac are frequently reported in methanol adulteration cases due to high demand and ease of falsification. |
High outbreak potential with severe toxicity, blindness, and death. |
|
Fermented beverages |
Beer, draft beer, wine, and cider usually contain minimal methanol from fermentation, but may be adulterated in informal markets. |
Lower baseline risk but still relevant for surveillance. |
|
Russia (2016; 2025) |
Surrogate alcohol and adulterated beverages containing methanol caused dozens of deaths in Irkutsk and the Leningrad region. |
Illustrates extreme lethality and repeated outbreaks. |
|
India (Punjab, 2025) |
Illicit locally produced alcohol contaminated with methanol led to multiple deaths and hospitalizations. |
Shows persistence of outbreaks in informal production systems. |
|
Indonesia and Malaysia (2018) |
Illegal alcoholic beverages adulterated with methanol caused over 80 deaths and more than 140 hospitalizations. |
Demonstrates large-scale outbreak capacity. |
|
Spain (1963) |
The historic methanol adulteration scandal resulted in deaths and widespread blindness. |
Classic example of long-term sequelae. |
|
Cuba (2013–2014) |
The illegal methanol trade caused the intoxication of over one hundred people; perpetrators received long prison sentences. |
Highlights criminal accountability and deterrence. |
|
Turkey (2025) |
Large-scale methanol poisoning outbreaks reported in major urban centers, including Istanbul (approximately 235 cases) and Ankara (approximately 94 cases), associated with adulterated alcoholic beverages. |
Illustrates persistence of high-magnitude outbreaks despite regulatory frameworks. |
In contrast, fermented beverages such as beer, draft beer, and wine typically generate minimal methanol during production; however, adulteration remains a possibility in informal markets. The table also presents selected international outbreaks illustrating the global recurrence of methanol-related intoxication, including events in Europe, Asia, and Latin America, which resulted in high mortality, irreversible visual impairment, and significant neurological sequelae. Together, these examples highlight common structural determinants such as illicit production, weak regulatory oversight, and limited traceability that underlie methanol poisoning outbreaks worldwide and reinforce their relevance as a preventable public health problem.
Analysis of exposure characteristics and international evidence indicates that distilled beverages are disproportionately represented in methanol adulteration events, particularly vodka, gin, cachaça, whisky, rum, tequila, and cognac. These products were consistently reported in outbreak investigations due to their high market demand, ease of falsification, and the ability of strong flavors to mask adulteration. In contrast, fermented beverages such as beer, draft beer, and wine generally present minimal methanol formation during production, although adulteration remains possible in informal markets. A comparative overview of beverages at highest risk and selected international outbreaks associated with methanol-contaminated alcohol is presented in Table 11.
Taken together, these findings provide a comprehensive descriptive framework that supports a broader interpretative discussion on the clinical severity, structural determinants, and public health implications of methanol-related alcohol adulteration.
4.0. DISCUSSION
The present findings reinforce that methanol-related intoxication represents one of the most severe forms of alcohol poisoning, distinguished by high lethality and irreversible clinical outcomes (Hay, 2017; Nekoukar et al., 2021; Alrashed et al., 2024). Unlike ethanol intoxication, which is often dose-dependent and generally reversible, methanol exposure leads to delayed but profound metabolic toxicity driven by the accumulation of formic acid and the subsequent development of severe metabolic acidosis (Barceloux et al., 2002; Kraut and Mullins, 2018). International outbreak alerts further corroborate the clinical patterns observed in this analysis, consistently describing a characteristic delay of 2 to 48 hours between ingestion and symptom onset.
Gastrointestinal complaints, visual disturbances, progressive metabolic acidosis, and neurological deterioration typically follow this latent period. The nonspecific nature of early symptoms frequently contributes to under-recognition of methanol poisoning, particularly when manifestations resemble those of alcohol hangover or uncomplicated ethanol intoxication. Such diagnostic delays significantly worsen prognosis and increase the likelihood of irreversible sequelae or death, reinforcing the need for heightened clinical suspicion during outbreak situations (PAHO/WHO, 2025).
The outbreak pattern observed in 2025 supports the interpretation of point-source contamination linked to adulterated batches rather than sporadic individual exposure, a configuration consistently reported in large-scale methanol outbreaks across different geographic settings (Zakharov et al., 2014; Gulen et al., 2020). Similar outbreak dynamics have been documented in diverse international contexts, underscoring the global relevance of this preventable public health problem and highlighting the need for coordinated surveillance systems, regulatory enforcement, and rapid risk communication strategies (Figure 3) (Manning and Kowalska, 2021; Movendi International, 2025).
Figure 3: Metabolic basis of antidotal therapy in methanol poisoning. Preferential binding of the antidote to Alcohol Dehydrogenase (ADH) inhibits the conversion of methanol to formaldehyde, thereby reducing downstream formation of the toxic metabolite formic acid
The predominance of permanent sequelae among survivors, particularly visual impairment and neurological damage, highlights the substantial long-term burden imposed by methanol poisoning (Zakharov et al., 2014; Rym et al., 2023; Fedrigo et al., 2025). Visual toxicity remains a defining clinical hallmark of methanol intoxication, frequently progressing to irreversible blindness even when acute survival is achieved. This outcome reflects the marked vulnerability of the optic nerve and visual pathways to methanol metabolites, particularly formic acid, which disrupts mitochondrial function and cellular energy metabolism (Luo et al., 2022; Nagendran et al., 2025).
Neurological sequelae further compound the burden of disease by affecting functional independence and overall quality of life through persistent cognitive, sensory, and motor impairments (Nikoo et al., 2022; Simani et al., 2022). In several cases, visual and neurological deficits coexist, indicating multisystem injury and reinforcing the complexity of post-acute care needs. Collectively, these outcomes demonstrate that mortality alone substantially underestimates the true impact of methanol outbreaks, which extend into chronic health, social, and economic domains and impose sustained demands on healthcare systems, rehabilitation services, and long-term social support structures (Figure 4) (Hay, 2017; Alhusain et al., 2024).Parte inferior do formulário
Figure 4: Role of folinic acid in the metabolism of formic acid during methanol poisoning. Folinic acid enhances the folate-dependent pathway, promoting the conversion and clearance of formic acid through tetrahydrofolate (THF)–mediated reactions, thereby reducing the accumulation of the toxic metabolite
Geographic clustering and the concentration of cases among socially vulnerable populations emphasize the central role of structural determinants in shaping exposure risk to methanol-contaminated beverages (Manning and Kowalska, 2021; OECD, 2022; Movendi International, 2025). Informal alcohol markets, limited regulatory oversight, and persistent economic constraints facilitate the circulation of illicit beverages and delay access to timely healthcare services, thereby amplifying both exposure risk and clinical severity once intoxication occurs (Alrashed et al., 2024; Bryan et al., 2024). In these contexts, delayed diagnosis and restricted access to specialized care further exacerbate outcomes, particularly during outbreak situations.
The recurrence of such outbreaks suggests persistent gaps in surveillance systems and intersectoral coordination, especially in settings characterized by fragmented regulatory capacity and limited traceability of alcohol products (MSF Norway et al., 2019; Anvisa, 2025). These findings align with international evidence indicating that methanol poisoning is more closely linked to social inequality, informal market dynamics, and regulatory fragility than to individual consumption behavior alone. This reinforces the need for structural prevention strategies that address upstream determinants of risk, including enforcement, traceability, and public risk communication (Figure 5) (Hay, 2017; Nekoukar et al., 2021).
Figure 5: Role of bicarbonate therapy in methanol poisoning. Accumulation of formic acid leads to metabolic acidosis, which is counteracted by bicarbonate administration, promoting partial restoration of systemic pH balance
The predominance of distilled beverages in methanol-related outbreaks observed in this study is consistent with international evidence, which identifies spirits as the primary vehicles for large-scale poisoning events due to their higher alcohol content and susceptibility to adulteration (Hay, 2017; Bryan et al., 2024). Historical and contemporary outbreaks reported in Europe, Asia, and Latin America demonstrate that vodka, whisky, gin, and locally produced spirits are frequently implicated, often as a result of illicit production practices, substitution with industrial alcohols, and distribution through informal channels (Zakharov et al., 2014; Gulen et al., 2020; Manning and Kowalska, 2021).
The alert also reinforces standardized management strategies for suspected methanol intoxication, emphasizing the need for early clinical recognition and prompt therapeutic intervention. Recommended measures include the immediate initiation of alcohol dehydrogenase inhibition with fomepizole or pharmaceutical-grade ethanol, correction of metabolic acidosis, folate supplementation to enhance formate metabolism, and the timely use of hemodialysis in severe cases. Together, these interventions aim to limit the accumulation of toxic metabolites and reduce the risk of irreversible organ damage. These recommendations align closely with established international toxicology guidelines and underscore the importance of maintaining antidote availability, laboratory readiness, and clearly defined referral pathways during outbreak scenarios (PAHO/WHO, 2025).
The response of health authorities during the outbreak illustrates both progress and ongoing challenges in the detection and management of methanol poisoning events (Anvisa, 2025; Brazil Agency, 2025b; CNN Brazil, 2025). While the severity of clinical presentations prompted regulatory actions, product seizures, and public alerts, delays in widespread risk communication and coordinated intersectoral response were evident, potentially allowing continued exposure before effective containment was achieved (Food Safety News, 2025; Movendi International, 2025). According to statements from the Secretary of Health of the State of São Paulo, approximately 20 alcohol-related deaths represent an upper reference threshold, with values above this level indicating a critical epidemiological situation requiring escalation of response. The exceedance of this threshold during the outbreak supports its classification as a public health emergency, underscoring the need for faster notification, integrated surveillance, and coordinated regulatory and clinical action to mitigate avoidable harm (Figure 6) (City Hall of São Paulo – COVISA, 2025; U.S. Embassy and Consulates in Brazil, 2025).
Figure 6: Role of hemodialysis in severe methanol poisoning. Hemodialysis facilitates the rapid removal of methanol, formaldehyde, and formic acid from the circulation, while also correcting metabolic acidosis, thereby reducing systemic toxicity
The widespread use of alcohol-based disinfectants during the COVID-19 pandemic introduced additional intoxication pathways unrelated to adulterated beverages. Reports worldwide documented severe poisonings linked to the ingestion of hand sanitizers, including cases involving contaminated, improperly formulated, or highly concentrated products. In Brazil, official alerts regarding inappropriate ingestion of non-beverage alcohols further highlighted the risks associated with increased availability, unsafe handling, and inadequate labeling of these products. Incorporating these exposure pathways into prevention strategies and risk communication is therefore crucial for reducing avoidable intoxications during public health emergencies (Holzman et al., 2021; Mousavi-Roknabadi et al., 2022; U.S. Department of Agriculture, 2025).
During the COVID-19 pandemic, several surveillance reports documented that up to 20–30% of reported toxic alcohol exposures were associated with non-beverage alcohol products, including hand sanitizers and industrial alcohols, highlighting the emergence of exposure pathways distinct from illicit alcoholic beverages (PAHO/WHO, 2025). These findings underscore the evolving landscape of toxic alcohol exposure and the need for adaptive surveillance strategies. Several limitations of this study must be acknowledged. The analysis relied on secondary data sources and narrative reports, which are subject to underreporting, incomplete follow-up, and regional variability in notification practices, particularly during outbreak situations (PAHO/WHO, 2025).
The absence of standardized national datasets precluded quantitative meta-analysis and precise estimation of mortality or sequelae rates, a challenge frequently reported in methanol outbreak investigations (Zakharov et al., 2014; Güler et al., 2024). Additionally, incomplete traceability of illicit products limited the reconstruction of exposure pathways and source attribution, constraining regulatory and enforcement analyses (OECD, 2022; Bryan et al., 2024). Despite these constraints, the convergence of clinical, surveillance, and literature-based evidence supports the robustness of the observed patterns and their relevance for public health action (MSF Norway et al., 2019; Anvisa, 2025).
Among survivors of acute methanol poisoning, international case series indicate that visual impairment affects approximately 30–60% of patients, with irreversible blindness reported in 10–30%, while persistent neurological sequelae occur in roughly 20–40% of cases. These figures underscore the substantial burden of long-term disability extending well beyond acute mortality and reinforce the need for sustained post-acute care and rehabilitation strategies (Figure 7) (PAHO/WHO, 2025).
Figure 7: Pathophysiological effects of formic acid accumulation in methanol poisoning. Formic acid inhibits mitochondrial oxidative phosphorylation, particularly in tissues with high metabolic demand, such as the optic nerve and central nervous system, leading to visual impairment and neurological toxicity
Future perspectives should prioritize the development of harmonized surveillance systems capable of early detection of atypical alcohol poisoning clusters, thereby enabling rapid and accurate differentiation between ethanol- and methanol-related events (Hay, 2017; Nekoukar et al., 2021). Early recognition of unusual clinical and epidemiological patterns is essential to prevent delays in diagnosis, reduce severe outcomes, and limit the scale of outbreaks. Strengthening laboratory capacity, including access to confirmatory testing and metabolic markers, alongside real-time data sharing and interdisciplinary collaboration between toxicology services, public health authorities, and regulatory agencies, is critical to improving outbreak response and reducing delays in clinical intervention (Kraut and Mullins, 2018; MSF Norway et al., 2019). Such integration facilitates coordinated decision-making across clinical, surveillance, and enforcement domains.
International experience further indicates that integrated surveillance systems, when combined with robust traceability mechanisms and coordinated regulatory action, can substantially mitigate the impact of methanol outbreaks and prevent recurrence. Sustained investment in these structural measures has been shown to improve early warning capacity, enhance product recall efficiency, and strengthen public risk communication, ultimately reducing morbidity and mortality associated with toxic alcohol exposure (Figure 8) (Manning and Kowalska, 2021; OECD, 2022; Movendi International, 2025).
Figure 8: Comparative tissue toxicity of ethanol and methanol. Ethanol metabolism leads to acetate formation with preservation of normal cellular function, whereas methanol metabolism results in formic acid accumulation, which preferentially targets the optic nerve and central nervous system, causing mitochondrial dysfunction and tissue injury
Expanding research beyond clinical outcomes to include prevention strategies, risk communication approaches, and systematic policy evaluation may substantially reduce the recurrence and severity of future methanol poisoning outbreaks (Manning and Kowalska, 2021; OECD, 2022; Movendi International, 2025). Evidence from international outbreak responses consistently suggests that sustained investments in regulation, product traceability, and public awareness are more effective than reactive, short-term interventions focused solely on acute clinical management (Hay, 2017; MSF Norway et al., 2019; Bryan et al., 2024). Addressing methanol intoxication, therefore, requires long-term structural interventions targeting informal alcohol markets, surveillance systems, and governance capacity, rather than reliance on emergency responses alone (Figure 9) (Nekoukar et al., 2021; Alrashed et al., 2024).
Figure 9: Integrated schematic of methanol poisoning management. Methanol is metabolized to formaldehyde and formic acid via alcohol dehydrogenase (ADH), a process inhibited by antidotal therapy. Accumulated formic acid targets the optic nerve and central nervous system, causing mitochondrial dysfunction. Supportive treatment includes bicarbonate for metabolic acidosis correction and hemodialysis for removal of methanol, formaldehyde, and formic acid
In outbreak settings, approximately one-third to one-half of affected patients require hemodialysis, reflecting the severity of metabolic acidosis and the need for rapid removal of methanol and its toxic metabolites (PAHO/WHO, 2025). Clinical alerts reinforce standardized management strategies for suspected methanol intoxication, including prompt initiation of alcohol dehydrogenase inhibition with fomepizole or pharmaceutical-grade ethanol, correction of metabolic acidosis, folate supplementation to enhance format clearance, and timely use of hemodialysis in severe cases. These recommendations are consistent with international toxicology guidelines and underscore the importance of maintaining antidote availability, laboratory readiness, and clearly defined referral pathways during outbreak scenarios (PAHO/WHO, 2025).
Published outbreak investigations further indicate that case fatality rates for methanol poisoning typically range from approximately 10% to over 30%, markedly exceeding those observed for ethanol-related intoxication, which generally remain below 1–2% in most surveillance settings (PAHO/WHO, 2025). Despite this severity, international experience indicates that methanol poisoning remains substantially underreported, as many outbreaks are never formally identified as methanol-related events, leading to systematic underestimation of incidence and mortality (MSF Norway et al., 2019; Nekoukar et al., 2021).
In Brazil, recent governmental actions, including the establishment of an intersectoral committee to address methanol intoxication, reflect growing institutional recognition of the need for coordinated surveillance, regulatory enforcement, and engagement with the alcoholic beverage sector (Anvisa, 2025; Brazil Agency, 2025b). While such initiatives represent important progress, international evidence suggests that sustained prevention depends on long-term investment in traceability systems, laboratory capacity, and effective risk communication, rather than reactive responses limited to outbreak periods (Hay, 2017; Manning and Kowalska, 2021; OECD, 2022).
5.0. CONCLUSION
Methanol-contaminated distilled beverages remain a severe yet preventable cause of alcohol-related intoxication, with outbreak configurations producing disproportionate mortality and a high burden of irreversible sequelae. The findings of this study demonstrate that the public health impact of methanol poisoning extends well beyond acute deaths, encompassing permanent visual and neurological impairment with long-term social, economic, and healthcare consequences. These outcomes impose sustained demands on health systems, rehabilitation services, and social support structures, particularly in vulnerable populations.
The study also highlights the critical importance of differentiating methanol intoxication from ethanol-related events, including exposures involving fuel or industrial ethanol and alcohol-based disinfectants, which may present with overlapping clinical features but carry distinct toxicological risks. Failure to distinguish these exposure pathways can delay appropriate management and hinder effective surveillance and regulatory response. Strengthening integrated surveillance systems, regulatory enforcement, product traceability, and risk communication—especially within informal markets and socially vulnerable settings is essential to prevent future outbreaks and reduce avoidable harm. Coordinated public health action that combines clinical preparedness, laboratory capacity, regulatory oversight, and public awareness remains fundamental to mitigating the ongoing risk posed by toxic alcohol exposure and to preventing the recurrence of large-scale methanol poisoning events.
Parte superior do formulário
Parte inferior do formulário
REFERENCES
- Abdelhamid, W. G., El-Sarnagawy, G. N., & Sobe, Z. K. (2024). Outcome assessment of acute methanol poisoning: A risk-prediction nomogram approach for in-hospital mortality. Toxicology Reports, 13, 101817.
- Ahmadi, S. et al. (2025). Clinical and laboratory prognostic factors associated with outcomes in methanol poisoning. Journal of the Intensive Care Society, 26, 1–10.
- Alhusain, F. et al. (2024). Clinical presentation and management of methanol poisoning outbreaks in Riyadh, Saudi Arabia: A retrospective analysis. BMC Emergency Medicine, 24, 1–12.
- Alrashed, M. et al. (2024). The perils of methanol exposure: Insights into toxicity and public health implications. Toxics, 12(12), 924.
- (2025). Alerta sanitário sobre risco de bebidas alcoólicas adulteradas e intoxicação por metanol. Retrieved January 8, 2026, from https://www.gov.br/anvisa
- AP News. (2025). Brazilians avoid drinking after authorities confirm methanol poisoning cases, including 1 death. Retrieved January 8, 2026, from https://apnews.com
- Banagozar-Mohammadi, A. et al (2020). Status of clinical toxicology education and ethics in medical education. Journal of Medical Ethics and History of Medicine, 13, 1–9.
- Barceloux, D. G., Bond, G. R., Krenzelok, E. P., Cooper, H., & Vale, J. A. (2002). American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. Clinical Toxicology, 40(4), 415–446.
- Brazil Agency. (2025a). Brazil reports 209 suspected cases of methanol poisoning. Retrieved January 8, 2026, from https://agenciabrasil.ebc.com.br
- Brazil Agency. (2025b). Government established a protocol for cases of methanol poisoning. Retrieved January 8, 2026, from https://agenciabrasil.ebc.com.br
- Bryan, M. A. et al. (2024). Worldwide illicit and counterfeit alcoholic spirits: Problem detection and prevention. Journal of Food Safety and Hygiene, 15(2), 1–22.
- Cervantes, C. E. et al. (2020). Early dialysis in a rare case of combined toxic alcohol ingestion. Case Reports in Nephrology, 2020, 1–6.
- CNN Brazil. (2025). Beverages containing methanol: see the measures adopted by authorities so far. Retrieved Jan, 8, 2026, from https://www.cnnbrasil.com.br
- City Hall of São Paulo. (2025). Nota Técnica 01/2025: Orientações sobre intoxicação por metanol. Retrieved Jan, 8, 2026, from https://prefeitura.sp.gov.br
- Ellis, D. I., Muhamadali, H., Xu, Y., Eccles, R., Goodall, I., & Goodacre, R. (2019). Rapid through-container detection of fake spirits and methanol quantification with handheld Raman spectroscopy. Analyst, 144(1), 324–330.
- Ellis, D. I. et al. (2017). Through-container, extremely low concentration detection of multiple chemical markers of counterfeit alcohol using a handheld SORS device. Scientific Reports, 7(1), 12082.
- (2025). Methanol poisoning. Retrieved Jan, 8, 2026, from https://www.emra.org
- U.S. Embassy and Consulates in Brazil. (2025). Health alert: Methanol poisoning in Brazil (adulterated drinks). Retrieved Jan, 8, 2026, from https://br.usembassy.gov
- Fedrigo, P. A. et al. (2025). Manifestações neurológicas e oculares na intoxicação por metanol: revisão narrativa. Levantamento em Evidências em Saúde, 4(1), 1–12.
- Food Safety News. (2025). Brazil battles a methanol poisoning incident with 200 affected. Retrieved Jan, 8, 2026, from https://www.foodsafetynews.com
- Gulen, M. et al. (2020). Methanol poisoning in Turkey: Two outbreaks, a single-center experience. Human & Experimental Toxicology, 39(9), 1–10.
- Güler, S. et al. (2024). An outbreak of home distillation methanol poisoning: Clinical features and outcomes. Clinical Toxicology, 62(5), 1–9.
- Harbord, N. et al. (2020). Common toxidromes and the role of extracorporeal treatment. Seminars in Dialysis, 33(5), 1–12.
- Hay, A. W. (2017). Toxic alcohols and outbreaks: Clinical and public health lessons. Clinical Toxicology, 55(7), 1–8.
- Holzman, S. D. et al. (2021). Death by hand sanitizer: Syndemic methanol poisoning in the COVID-19 pandemic. Journal of Medical Toxicology, 17(3), 1–8.
- Illescas, A. C. et al. (2021). Severe methanol poisoning treated with a novel hemodialysis system: Case report. Case Reports in Nephrology, 2021, 1–6.
- Kraut, J. A., & Mullins, M. E. (2018). Toxic alcohols. New England Journal of Medicine, 378(3), 270–280.
- Lee, K. J. et al. (2024). Learning algorithms for identification of whisky using spectroscopic signals: Implications for counterfeit detection. Forensic Science International: Digital Investigation, 50, 301–312.
- Luo, L. et al. (2022). Severe visual loss caused by inhalational methanol exposure: Case series. Clinical & Experimental Ophthalmology, 50(3), 1–6.
- Manning, L., & Kowalska, A. (2021). Illicit alcohol: Public health risk of methanol poisoning and policy mitigation strategies. Foods, 10(7), 1625.
- (2026). New suspected methanol-related death: what is the status of poisoning cases in SP? Retrieved Jan, 8, 2026, from https://www.metropoles.com
- Mousavi-Roknabadi, R. S. et al. (2022). Methanol poisoning during the COVID-19 pandemic: A systematic scoping review. American Journal of Emergency Medicine, 52, 69–79.
- Movendi International. (2025). Brazil’s methanol poisoning outbreak revives calls for an alcohol tracking and tracing system. Retrieved Jan, 8, 2026, from https://movendi.ngo
- MSF Norway, Oslo University Hospital, & EMACC-WG. (2019). Methanol poisoning outbreak response protocol. Retrieved January 8, 2026, from https://methanolpoisoning.msf.org
- Mullins, M. E. (2022). The role of the nephrologist in management of poisoning and intoxication: Core Curriculum 2022. American Journal of Kidney Diseases, 79(6), 1–14.
- Nagendran, V. et al. (2025). Methanol toxicity: Characteristics, ophthalmological sequelae and recommended treatment. Eye, 39, 1–12.
- Nekoukar, Z. et al. (2021). Methanol poisoning as a new world challenge: A review. Toxin Reviews, 40(4), 1–14.
- Nikoo, M. H. et al. (2022). Mortality-related electrocardiogram indices in methanol poisoning. BMC Emergency Medicine, 22, 1–10.
- (2022). Illicit trade in high-risk sectors. Retrieved Jan, 8, 2026, from https://www.oecd.org
- Pan American Health Organization / World Health Organization (PAHO/WHO). (2025). Epidemiological alert: Risk of methanol poisoning associated with adulterated alcoholic beverages. Washington, DC: PAHO/WHO.
- (2025a). 3 dead, more than 200 poisoned from tainted alcohol. Retrieved Jan, 8, 2026, from https://people.com
- (2025b). The boyfriend of an influencer dies after consuming the same beverage. Retrieved Jan, 8, 2026, from https://people.com
- Rasamison, R. et al. (2020). Analysis of fomepizole safety based on a 16-year post-marketing experience in France. Clinical Toxicology, 58(3), 1–10.
- Rym, M. et al. (2023). Ocular manifestations after acute methanol poisoning. BMJ Open Ophthalmology, 8(1), e001234.
- Salehtabari, Y. et al. (2025). Alcohol poisoning in the shadow of a COVID-19 pandemic: Ethanol versus methanol outcomes. BMC Public Health, 25, 1–12.
- Shoormasti, K. A. et al. (2024). Methanol poisoning and its clinical complications during the COVID-19 pandemic: Systematic review. Iranian Journal of Psychiatry and Behavioral Sciences, 18(2), 1–12.
- Skaaland, H. et al. (2020). Reference values for osmolal gap in healthy subjects and medical patients. Clinical Chemistry and Laboratory Medicine, 58(6), 1–9.
- Simani, L. et al. (2022). The outbreak of methanol intoxication during the COVID-19 pandemic: Clinical and imaging correlates. Neuroradiology, 64(4), 1–12.
- The Guardian. (2025). Brain damage, blindness, and death: The global trail of trauma left by methanol-laced alcohol. Retrieved Jan, 8, 2026, from https://www.theguardian.com
- The Washington Post. (2025). Ten dead from tainted liquor; Brazil police probe organized crime ties. Retrieved Jan, 8, 2026, from https://www.washingtonpost.com
- S. Department of Agriculture. (2025). Poisoned counterfeit distilled spirits cause demand to drop (Brazil). Retrieved Jan, 8, 2026, from https://apps.fas.usda.gov
- Yip, L. et al. (2020). Methanol poisoning from ingestion of alcohol-based hand sanitizers: Arizona and New Mexico, May–June 2020. Morbidity and Mortality Weekly Report, 69(32), 1070–1073.
- Yurtsever, G. et al. (2022). Methanol poisoning in the emergency department: Clinical features and outcomes. Turkish Journal of Emergency Medicine, 22(3), 1–8.
- Zakharov, S. et al. (2014). Czech mass methanol outbreak 2012: Epidemiology, clinical characteristics and predictors of mortality. Clinical Toxicology, 52(10), 1–10.